desoxycorticosterone has been researched along with Vasculitis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dilley, R; Funder, JW; Moussa, L; Young, MJ | 1 |
Funder, J; Young, M | 1 |
Funder, JW; Young, M | 1 |
Bowers, MC; Dipette, DJ; Fink, G; Katki, KA; Patel, P; Rao, A; Steficek, B; Supowit, SC; Zhao, H | 1 |
Amiri, F; Javeshghani, D; Ko, EA; Leibovitz, E; Pandey, NR; Schiffrin, EL; Touyz, RM | 1 |
Fuller, PJ; Funder, JW; Morgan, J; Rickard, AJ; Young, MJ | 1 |
6 other study(ies) available for desoxycorticosterone and Vasculitis
Article | Year |
---|---|
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Blood Pressure; Carbenoxolone; Cardiomegaly; Coronary Disease; Desoxycorticosterone; Enzyme Inhibitors; Eplerenone; Fibrosis; Heart; Hydroxysteroid Dehydrogenases; Kidney; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solutions; Spironolactone; Vasculitis | 2003 |
Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis.
Topics: Animals; Anti-Arrhythmia Agents; Canrenoic Acid; Desoxycorticosterone; Fibrosis; Guanidines; Heart Diseases; Hydrogen; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchangers; Sulfones; Vasculitis | 2003 |
Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats.
Topics: Animals; Biomarkers; Coronary Vessels; Desoxycorticosterone; Eplerenone; Fibrosis; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium Chloride, Dietary; Spironolactone; Vasculitis | 2004 |
Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage.
Topics: Albuminuria; Animals; Aorta; Blood Pressure; Calcitonin Gene-Related Peptide; Capillaries; Coronary Disease; Desoxycorticosterone; Femoral Artery; Glomerular Mesangium; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Male; Mice; Mice, Knockout; Myocarditis; Myocytes, Cardiac; Nephrectomy; Organ Size; Sodium Chloride, Dietary; Telemetry; Vasculitis | 2005 |
Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice.
Topics: Animals; Biomarkers; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Hypertension; Macrophage Colony-Stimulating Factor; Macrophages; Mesenteric Arteries; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Osteopetrosis; Reactive Oxygen Species; Superoxides; Vascular Resistance; Vasculitis | 2007 |
Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
Topics: Animals; Biomarkers; Blood Pressure; Cardiomegaly; Cardiomyopathies; Coronary Vessels; Desoxycorticosterone; Drug Administration Schedule; Eplerenone; Fibrosis; Hormone Antagonists; Male; Mifepristone; Myocardium; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Sodium Chloride; Spironolactone; Vasculitis | 2007 |